About ShiraTronics
ShiraTronics is a company based in Minneapolis (United States) founded in 2019. ShiraTronics has raised $107.69 million across 3 funding rounds from investors including LivaNova, Norwest Venture Partners and Seroba Lifesciences. ShiraTronics offers products and services including Neuromodulation Device. ShiraTronics operates in a competitive market with competitors including ElectroCore, eNeura, Cefaly, Salvia BioElectronics and Zosano Pharma, among others.
- Headquarter Minneapolis, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Shiratronics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$107.69 M (USD)
in 3 rounds
-
Latest Funding Round
$66 M (USD), Series B
Sep 17, 2024
-
Investors
LivaNova
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ShiraTronics
ShiraTronics offers a comprehensive portfolio of products and services, including Neuromodulation Device.
Implanted device for nerve stimulation to relieve chronic migraine symptoms.
People of ShiraTronics
Unlock access to complete
Funding Insights of ShiraTronics
ShiraTronics has successfully raised a total of $107.69M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $66 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ShiraTronics
ShiraTronics has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include LivaNova, Norwest Venture Partners and Seroba Lifesciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Amzak Health is engaged in venture investments in life sciences.
|
Locked | Locked | Locked |
Investor details for ShiraTronics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ShiraTronics
Investment portfolio details for ShiraTronics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ShiraTronics
Detailed financials for ShiraTronics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Shiratronics Comparisons
Peer comparison for ShiraTronics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ShiraTronics
ShiraTronics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ElectroCore, eNeura, Cefaly, Salvia BioElectronics and Zosano Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive vagus nerve stimulation devices are developed for headache treatments.
|
|
| Locked | Locked | Locked |
Transcranial magnetic stimulation devices for migraine treatment are developed.
|
|
| Locked | Locked | Locked |
Neurostimulation devices for migraine and headache treatment are provided.
|
|
| Locked | Locked | Locked |
Bioelectronic solutions for migraines and neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
Detailed competitors of ShiraTronics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Shiratronics
Complete news archive for ShiraTronics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ShiraTronics
ShiraTronics was founded in 2019.
ShiraTronics is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
ShiraTronics is a funded company, having raised a total of $107.69M across 3 funding rounds to date.
ShiraTronics was founded in 2019 as a spinout from NuXcel and is based in Minneapolis, United States. Focus is placed on the development of implantable neuromodulation devices targeted at migraines and other chronic conditions. Partnerships with entities such as AMZAK, APERTURE, and LivaNova support operations in the medical device sector. Activities center on advancing neuromodulation technologies for therapeutic applications.
ShiraTronics's top competitors include Salvia BioElectronics, ElectroCore and eNeura.
ShiraTronics offers Neuromodulation Device.
ShiraTronics has 11 investors. Key investors include LivaNova, Norwest Venture Partners, Seroba Lifesciences, OSF Ventures, and Amzak Health.